PIPAC is a specialised treatment approach that may be considered for selected cancers involving the peritoneum as part of an individualised cancer care plan.
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) delivers chemotherapy into the abdominal cavity as a pressurised aerosol. Its suitability is assessed according to the cancer type, extent of disease, previous treatments and the patient's overall health.
PIPAC may be considered in selected situations involving peritoneal disease from cancers such as stomach and ovarian cancer, as well as peritoneal malignancies such as mesothelioma and pseudomyxoma peritonei. Its role depends on the individual clinical situation and how it fits within the broader treatment plan.
For patients exploring PIPAC cancer treatment, it is important to understand that the procedure may form part of a wider treatment strategy. Depending on the cancer and its characteristics, care may also involve surgery, chemotherapy, targeted therapy and immunotherapy. Imaging, pathology, previous treatment history and disease distribution can help guide these decisions.
Dr. Ninad V. Katdare's experience in peritoneal surface malignancies includes evaluating specialised treatment approaches according to disease distribution and previous treatment.
PIPAC is one of several approaches used in the management of peritoneal malignancies. Treatment planning focuses on matching the selected approach with the nature and extent of disease, previous therapies and the patient's individual treatment objectives.
For patients seeking a clearer understanding of advanced peritoneal cancer treatment options in Dadar, Dr Ninad Katdare Cancer Surgeon can explain how PIPAC and other approaches may be evaluated for an individual clinical situation.
